INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.36 Cr | ₹13 Cr | ₹12 Cr | ₹6.14 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDOCO REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹4.36 Cr |
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹6.14 Cr |
| Mar2022 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of INDOCO REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.36 Cr | -67.34 | |
| Mar2025 | ₹13 Cr | 12.93 | |
| Mar2024 | ₹12 Cr | 92.58 | |
| Mar2023 | ₹6.14 Cr | -42.06 | |
| Mar2022 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,238.3 Cr | 1.5% | 9% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 1.5% |
9% |
-12.2% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses